| Barmat LI, Chantilis SJ, Hurst BS, et al.
A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Fertil Steril 2005 Feb; 83(2):321-30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Duramed Pharmaceuticals targets women's health. [Journal Article]
Contracept Technol Update 2000 Feb; 21(2):19-21.
Full Citation | Find Related Articles | | Charnock-Jones DS, Macpherson AM, Archer DF, et al.
The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. [Journal Article]
Hum Reprod 2000 Aug.:85-95.
Abstract | Full Citation | Find Related Articles | | Gazzaz M, Sichez J, Capelle L, et al.
[Recurrent bleeding of thalamic cavernous angioma under hormonal treatment. A case report] [Case Reports, Journal Article]
Neurochirurgie 1999 Dec; 45(5):413-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Rosenberg MJ, Meyers A, Roy V
Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Contraception 1999 Dec; 60(6):321-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Macpherson AM, Archer DF, Leslie S, et al.
The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium. [Clinical Trial, Journal Article]
Hum Reprod 1999 Dec; 14(12):3080-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Branigan EF, Estes MA
Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using oral contraceptive ovarian suppression followed by repeat CC treatment. [Clinical Trial, Journal Article]
Fertil Steril 1999 Mar; 71(3):544-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Killick SR, Fitzgerald C, Davis A
Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Am J Obstet Gynecol 1998 Jul; 179(1):S18-24.
Abstract | Full Citation | Find Related Articles | | Berga SL
Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette. [Clinical Trial, Journal Article, Multicenter Study]
Am J Obstet Gynecol 1998 Jul; 179(1):S9-17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group. [Clinical Trial, Journal Article, Multicenter Study]
Am J Obstet Gynecol 1998 Jul; 179(1):S2-8.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
